-
Published14/08/2026
-
Today05/09/2026
-
Deadline18/09/2026
-
Opening of tenders18/09/2026
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Supply of pharmaceutical products for gene therapy
The overall objective is to purchase a drug to provide treatment for paediatric patients diagnosed with spinal muscular atrophy who can reap the benefits of advanced therapy such as gene therapy. The number of days until which clarifications can be requested before the deadline for submission of tenders/candidates is 18. The contracting authority will respond clearly and completely to all requests for clarification/additional information on the 11th day before the deadline set for the submission of tenders - cf. Article 160(2) in conjunction with Article 161(1) of Law 98/2016.
https://www.e-licitatie.ro
https://www.e-licitatie.ro
33661000 - Medicinal products for the nervous system
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33632000 - Medicinal products for the musculo-skeletal system
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.